Issue of Warrants

Source: RNS
RNS Number : 0184O
Quadrise Fuels International PLC
27 September 2019
 

27 September 2019

Quadrise Fuels International plc

("Quadrise", "QFI" or "the Company")

Issue of Warrants

The Company announces that, following the general meeting of the Company held on 27 September 2019, the Company has today issued 4,900,000 warrants to subscribe for new ordinary shares in the Company, at any point until 36 months from the date of issue, at a current exercise price of 5.78 pence per new ordinary share pursuant to, and on and subject to the terms and conditions set out in, a warrant instrument dated 27 September 2019, the details of which were announced by the Company on 23 August 2019.

For further information, please refer to the Company's website at www.quadrisefuels.com, or contact ir@quadrisefuels.com or phone:

 

Quadrise Fuels International Plc

 

Mike Kirk, Executive Chairman

+44 (0)20 7031 7321

Jason Miles, Chief Operating Officer

 

 

 

Nominated Adviser

 

Cenkos Securities plc

 

Dr Azhic Basirov

+44 (0)20 7397 8900

Ben Jeynes

Katy Birkin

 

 

 

Joint Brokers

 

Peel Hunt LLP

 

Richard Crichton

+44 (0)20 7418 8900

Ross Allister 

 

 

 

Shore Capital Stockbrokers Limited

 

Daniel Harris

Andy Crossley

+44 (0)20 7601 6108

 

 

Public & Investor Relations

 

FTI Consulting

 

Ben Brewerton

+44 (0)20 3727 1000

Ntobeko Chidavaenzi

 

Notes to Editors

QFI is the supplier of MSAR® emulsion technology and fuels, a low-cost alternative to heavy fuel oil (one of the world's largest fuel markets, comprising over 450 million tons per annum) in the global shipping, refining and steam and power generation industries.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IODPGUCUBUPBGAM